Clinical and pharmacological group: & nbsp

Nootropics

Correctors of cerebral circulation disorders

Included in the formulation
  • Amilonosar®
    pills inwards 
    BIOCHEMIST, OJSC     Russia
  • Amilonosar®
    solution w / m in / in 
    BIOCHEMIST, OJSC     Russia
  • Pikamil®
    solution w / m in / in 
  • Picalon
    solution w / m in / in 
  • Picalon
    pills inwards 
    AKRIKHIN HFK, JSC     Russia
  • Pikamil®
    pills inwards 
  • Picanoloy®
    pills inwards 
    NPK ECHO, CJSC     Russia
  • АТХ:

    N.06.B.X   Other psychostimulants and nootropic drugs

    Pharmacodynamics:

    A combined preparation in which the gamma-aminobutyric acid and a nicotinic acid.

    Gamma-aminobutyric acid

    The main brake mediator of the central nervous system. Strengthens energy processes, increases oxygen consumption of tissues, normalizes blood supply, promotes the utilization of glucose in the brain. Improves thinking, dynamics of nervous processes in the brain, memory, promotes recovery of motor activity and speech after cerebral circulation disorders, has a mild psycho-stimulating effect.

    A nicotinic acid

    Is a substrate for the synthesis of nicotinadenine nucleotide (NAD-codeegirdase I) and nicotinadenine nucleotide phosphate (NADP-codeogirdase II), which accept and transfer protons in oxidation-reduction reactions, providing all types of exchange, including energy. It improves nitrogen and carbohydrate metabolism, provides tissue respiration.

    It has a vasodilating effect, improves microcirculation, manifests fibrinolytic activity by decreasing platelet aggregation. Has hypolipidemic activity, lowers the cholesterol / phospholipids in hypercholesterolemia.

    Pharmacokinetics:

    After ingestion, up to 88% is absorbed in the gastrointestinal tract. It is distributed in the tissues of the brain, kidneys, muscles and fat stores, for a long time it is kept in the body. Penetrates through blood-brain and placental barriers.

    It is not metabolized.

    The half-life is 50 minutes. Elimination of the kidneys in an unchanged form.

    Indications:

    It is used for cerebrovascular insufficiency, asthenic syndrome, vegetative-vascular dystonia, depressive disorders in old age. Used as part of complex therapy for the relief of acute alcohol intoxication, with migraine, nephroinfection, craniocerebral trauma.

    In order to stabilize the visual function is used for glaucoma. To improve the adaptive function of the bladder by reducing hypoxia detrusor is used in urological practice in adults and children older than 3 years.

    Used to increase the endurance of mental and physical intense and extreme conditions of activity, as well as to restore physical performance and increase resistance to mental stress.

    V.F30-F39.F33   Recurrent depressive disorder

    V.F30-F39.F31.5   Bipolar affective disorder, the current episode of severe depression with psychotic symptoms

    V.F30-F39.F31   Bipolar affective disorder

    V.F20-F29.F25.9   Schizoaffective disorder, unspecified

    V.F20-F29.F21   Chrysotile disorder

    V.F00-F09.F06.9   Mental disorder due to brain damage or dysfunction or somatic disease, unspecified

    V.F40-F48.F48.0   Neurasthenia

    VI.G40-G47.G43   Migraine

    XIV.N30-N39.N31.9   Neuromuscular dysfunction of urinary bladder, unspecified

    VI.G90-G99.G93.4   Encephalopathy, unspecified

    XXI.Z70-Z76.Z73.0   Overwork

    XXI.Z70-Z76.Z73.3   Stress condition, not elsewhere classified

    Contraindications:

    Chronic renal failure, individual intolerance of the components of the drug.

    Carefully:

    Acute disturbance of cerebral circulation.

    Pregnancy and lactation:

    Recommendations for FDA - category is not defined. No studies have been conducted. Contraindicated during pregnancy and lactation.

    Dosing and Administration:

    Inside, regardless of the time of food intake by 0,02-0,05 g 2-3 times / day.

    Parenteral: intravenously drip on 200 ml of 0.9% solution of sodium chloride to 0.1-0.2 g.

    The highest daily dose: 0.8 g.

    The highest single dose: 0.2 g.

    Side effects:

    Central and peripheral nervous system: irritability, anxiety, drowsiness, headache.

    Digestive system: nausea.

    Allergic reactions.

    Overdose:

    Increased side effects.

    Treatment is symptomatic.

    Interaction:

    Shortens the time of action of barbiturates and narcotic analgesics.

    Special instructions:

    When the drug is prescribed for the purpose of arresting a migraine, it is necessary to use a combination with β-adrenoreceptor blockers and psychotropic drugs.

    Instructions
    Up